Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival

Rheumatology

Volumn 50, Issue 2, 2011, Pages 278-282

  Moura, Rita A ^a   Cascão, Rita ^a   Perpétuo, Inês ^a   Canhão, Helena ^a,b   Vieira sousa, Elsa ^a,b   Mourão, Ana F ^a,c   Rodrigues, Ana M ^a,b   Polido Pereira, Joaquim ^a,b   Queiroz, Mário V ^b   Rosário, Henrique S ^a   Souto Carneiro, Maria M ^d   Graca, Luis ^a,e   Fonseca, João E ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c HOSPITAL EGAS MONIZ   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

APRIL; B cells; BAFF; Synovial fluid; VERA

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; CYTOKINE; INTERLEUKIN 21;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; POLYARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; CYTOKINES; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; STATISTICS AS TOPIC; SYNOVIAL FLUID; TIME FACTORS; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 78751692218     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq338     Document Type: Article

References (20)

1. Tak PP, Thurlings RM, Rossier C et al. Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single-, repeated-dose study. Arthritis Rheum 2008;58:61-72.
2. Edwards JC, Cambridge G. Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology 2001;40:205-11.
3. Leandro MJ, Edwards JC, Cambridge G. Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheum Dis 2002;61:883-8.
4. Moura RA, Weinmann P, Pereira PA et al. Alterations on peripheral blood B-cell subpopulations in very early arthritis patients. Rheumatology 2010;49:1082-92.
5. Souto-Carneiro MM, Mahadevan V, Takada K et al. Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor. Arthritis Res Ther 2009; 11:R84.
6. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
7. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
8. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23: 137-45.
9. Humby F, Bombardieri M, Manzo A et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009;6:e1.
10. Litinskiy MB, Nardelli B, Hilbert DM et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002;3: 822-9.
11. Castigli E, Scott S, Dedeoglu F et al. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA 2004;101:3903-8.
12. Castigli E, Wilson SA, Scott S et al. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 2005;201: 35-9.
13. Belnoue E, Pihlgren M, McGaha TL et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 2008;111:2755-64.
14. Bossen C, Cachero TG, Tardivel A et al. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 2008;111:1004-12.
15. Dong W, Li X, Liu H, Zhu P. Infiltrations of plasma cells in synovium are highly associated with synovial fluid levels of APRIL in inflamed peripheral joints of rheumatoid arthritis. Rheumatol Int 2009;29:801-6.
16. Gabay C, Krenn V, Bosshard C, Seemayer CA, Chizzolini C, Huard B. Synovial tissues concentrate secreted APRIL. Arthritis Res Ther 2009;11:R144.
17. Badr G, Borhis G, Lefevre EA et al. BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 2008;111:2744-54.
18. Ettinger R, Sims GP, Fairhurst AM et al. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 2005;175: 7867-79.
19. Barrera P, Boerbooms AM, Demacker PN, van de Putte LB, Gallati H, van der Meer JW. Circulating concentrations and production of cytokines and soluble receptors in rheumatoid arthritis patients: effects of a single dose methotrexate. Br J Rheumatol 1994;33: 1017-24.
20. Chikanza IC, Kozaci D, Chernajovsky Y. The molecular and cellular basis of corticosteroid resistance. J Endocrinol 2003;179:301-10.